Celiac Drugs Market Report – Research, Industry Analysis Reports and Market Demands

Global Celiac Drugs Market Insights, Forecast to 2025

Request for Sample of this report

Buy now

Table of Content

1 Study Coverage

1.1 Celiac Drugs Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
- 1.4.1 Global Celiac Drugs Market Size Growth Rate by Product
- 1.4.2 First Line Of Treatment
- 1.4.3 Second Line Of Treatment
1.5 Market by End User
- 1.5.1 Global Celiac Drugs Market Size Growth Rate by End User
- 1.5.2 Men
- 1.5.3 Women
- 1.5.4 Children
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary

2.1 Global Celiac Drugs Market Size
- 2.1.1 Global Celiac Drugs Revenue 2014-2025
- 2.1.2 Global Celiac Drugs Sales 2014-2025
2.2 Celiac Drugs Growth Rate by Regions
- 2.2.1 Global Celiac Drugs Sales by Regions
- 2.2.2 Global Celiac Drugs Revenue by Regions

3 Breakdown Data by Manufacturers

3.1 Celiac Drugs Sales by Manufacturers
- 3.1.1 Celiac Drugs Sales by Manufacturers
- 3.1.2 Celiac Drugs Sales Market Share by Manufacturers
- 3.1.3 Global Celiac Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Celiac Drugs Revenue by Manufacturers
- 3.2.1 Celiac Drugs Revenue by Manufacturers (2014-2019)
- 3.2.2 Celiac Drugs Revenue Share by Manufacturers (2014-2019)
3.3 Celiac Drugs Price by Manufacturers
3.4 Celiac Drugs Manufacturing Base Distribution, Product Types
- 3.4.1 Celiac Drugs Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Celiac Drugs Product Type
- 3.4.3 Date of International Manufacturers Enter into Celiac Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

4.1 Global Celiac Drugs Sales by Product
4.2 Global Celiac Drugs Revenue by Product
4.3 Celiac Drugs Price by Product

5 Breakdown Data by End User

5.1 Overview
5.2 Global Celiac Drugs Breakdown Data by End User

6 North America

6.1 North America Celiac Drugs by Countries
- 6.1.1 North America Celiac Drugs Sales by Countries
- 6.1.2 North America Celiac Drugs Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
6.2 North America Celiac Drugs by Product
6.3 North America Celiac Drugs by End User

7 Europe

7.1 Europe Celiac Drugs by Countries
- 7.1.1 Europe Celiac Drugs Sales by Countries
- 7.1.2 Europe Celiac Drugs Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
7.2 Europe Celiac Drugs by Product
7.3 Europe Celiac Drugs by End User

8 Asia Pacific

8.1 Asia Pacific Celiac Drugs by Countries
- 8.1.1 Asia Pacific Celiac Drugs Sales by Countries
- 8.1.2 Asia Pacific Celiac Drugs Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
8.2 Asia Pacific Celiac Drugs by Product
8.3 Asia Pacific Celiac Drugs by End User

9 Central & South America

9.1 Central & South America Celiac Drugs by Countries
- 9.1.1 Central & South America Celiac Drugs Sales by Countries
- 9.1.2 Central & South America Celiac Drugs Revenue by Countries
- 9.1.3 Brazil
9.2 Central & South America Celiac Drugs by Product
9.3 Central & South America Celiac Drugs by End User

10 Middle East and Africa

10.1 Middle East and Africa Celiac Drugs by Countries
- 10.1.1 Middle East and Africa Celiac Drugs Sales by Countries
- 10.1.2 Middle East and Africa Celiac Drugs Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
10.2 Middle East and Africa Celiac Drugs by Product
10.3 Middle East and Africa Celiac Drugs by End User

11 Company Profiles

12 Future Forecast

12.1 Celiac Drugs Market Forecast by Regions
- 12.1.1 Global Celiac Drugs Sales Forecast by Regions 2019-2025
- 12.1.2 Global Celiac Drugs Revenue Forecast by Regions 2019-2025
12.2 Celiac Drugs Market Forecast by Product
- 12.2.1 Global Celiac Drugs Sales Forecast by Product 2019-2025
- 12.2.2 Global Celiac Drugs Revenue Forecast by Product 2019-2025
12.3 Celiac Drugs Market Forecast by End User
12.4 North America Celiac Drugs Forecast
12.5 Europe Celiac Drugs Forecast
12.6 Asia Pacific Celiac Drugs Forecast
12.7 Central & South America Celiac Drugs Forecast
12.8 Middle East and Africa Celiac Drugs Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

14.1 Value Chain Analysis
14.2 Celiac Drugs Customers
14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
16.2 Author Details

Description

Celiac disease, also known as celiac sprue or gluten-sensitive enteropathy, is a genetic autoimmune disorder caused due to the body’s inability to process gluten that causes damage to the small intestine. Gluten, a protein found in wheat, barley, and rye, can damage the lining of the small intestine which makes it difficult for the body to absorb nutrients such as iron, fat, calcium, and folate. The immune system mistakes substances inside gluten to be a threat to the body and attacks them, in turn, causing damage to the bowel surface and hampering the body’s ability to absorb nutrition. Digestion problems, dermatitis herpetiformis, abdominal pain, weight loss, musculoskeletal problems, aphthous ulcers, iron deficiency, stunted growth, tingling sensation in the leg, and missed menstrual cycles are some of the symptoms of celiac disease. The disease can lead to various complications and health problems such as miscarriage or infertility, intestinal cancer, osteoporosis, seizures, gall bladder malfunction, neurological manifestation of the disease, stunted growth in children, and birth defects. Celiac disease can also lead to various autoimmune diseases such as lupus, thyroid disease, Sjögren's syndrome, type 1 diabetes, and rheumatoid arthritis. It is difficult to diagnose celiac disease in the initial stages as its symptoms are similar to those of other diseases. Various sensitive and selective blood tests such as anti-tissue transglutaminase antibodies with or without IgA level and IgA anti-endomysial antibodies are used to screen the disease.
North America dominates the global market for celiac drugs due to rising incidence of celiac disease and lack of treatment options in the region. Asia is expected to show high growth rates in the next five years in global celiac drugs market, with China and India being the fastest growing markets in the Asia-Pacific region. The key driving forces for the celiac drugs market in developing countries are the large pool of patients, increasing awareness about the disease, and rising government funding in the region.
The global Celiac Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Celiac Drugs market based on company, product type, end user and key regions.

This report studies the global market size of Celiac Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Celiac Drugs in these regions.
This research report categorizes the global Celiac Drugs market by top players/brands, region, type and end user. This report also studies the global Celiac Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
ADMA Biologics
Amgen
Anthera Pharmaceuticals
Bayer
Biogen
BioLineRx
Biotest
Bristol-Myers Squibb
Celgene
Celimmune
F Hoffmann-La Roche
ImmunogenX
Immunomedics
ImmusanT
Innovate Biopharmaceuticals
Johnson & Johnson
Kedrion Biopharma
LFB Group
Merck
Novartis

Market size by Product
First Line Of Treatment
Second Line Of Treatment
Market size by End User
Men
Women
Children

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Celiac Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Celiac Drugs market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Celiac Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Celiac Drugs submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Celiac Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Celiac Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.